Varenicline Articles
Research results for Pfizer's Chantix, Pristiq and Toviaz
27 January 2013
Pfizer acts to stop Mylan marketing generic Chantix; Allergan in $600 million settlement over Botox marketing practices
2 September 2010
The “new” Pfizer sees 4th qtr s2009 sales and profit rocket, but 2010 guidance disappoints
4 February 2010
US FDA backs safety of Pfizer/Boehringer’s Spiriva HandiHaler; Pfizer admits EU investigation; gets sued over Chantix
15 January 2010
GSK and Nabi in deal for NicVAX, with upfront and potential payments of over $500 million
17 November 2009
More smokers quit habit with Pfizer’s Champix than with placebo
6 November 2009
Pfizer 2009 3rd-qtr earnings beats forecasts, but sales weaken
21 October 2009
FDA eyes orlistat for potential liver problems, Chantix under scrutiny for skin reaction
5 June 2009
MHRA records 3,451 AE cases with Chantix
17 November 2008
Pfizer's 3rd-qtr 2008 profit triples due to Exubera write-off; revenues flat at $12B
27 October 2008
FDA faces US House on VA drug oversight
28 July 2008
Pfizer to launch Champix in Japan
28 April 2008
Pfizer moves to keep market share in Japan
24 March 2008
Good news for Pfizer's troubled Champix
18 February 2008
FDA asks Pfizer to add Chantix safety warnings
11 February 2008
Pfizer Japan gets approval for Champix
4 February 2008
Pfizer sees 4th-qtr 2007 profits decline, but still beats forecasts; revenue rises 4%
28 January 2008
Pfizer toughens Chantix label on depression
21 January 2008
EMEA recommends update on Champix label
24 December 2007
US FDA issues warning on Pfizer's Chantix
26 November 2007
Cancer Research UK Oks Champix approval
6 August 2007
NICE clears Champix for NHS
30 July 2007
UK's NICE recommends Pfizer's Champix
4 June 2007
Pfizer's 1st-qtr profits tumble 17.5%
30 April 2007
France's Afssaps to review four drugs
29 January 2007
Pfizer launches Champix in the UK
11 December 2006
Anti-addiction therapies market 2006-11 - Pharma's next Viagra?
6 November 2006
Pfizer's Champix approved in Europe
9 October 2006
Pfizer's Chantix goes on sales across the USA
14 August 2006
Pfizer's Champix gets CHMP positive opinion
7 August 2006
Pfizer's Chantix shows promise in trials
10 July 2006
US priority review for Pfizer's varenicline
9 January 2006
Varenicline, another Pfizer blockbuster?
30 June 2003
Showing 1-47 of 47 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
